Skip to main content
. 2019 Aug 6;34(11):1698–1705. doi: 10.1002/gps.5184

Table 5.

Results of the reliable change index comparisons

Parameter PD‐DBS vs. PD‐BMT PD‐DBS vs. MCI PD‐DBS vs. healthy control n Total
|d ppc2| |d ppc2| |d ppc2|
Depressive Symptoms (BDI‐II) .000 38.10 (n = 8) 19.05 (n = 4) 42.86 (n = 9) .067 38.10 (n = 8) 19.05 (n = 4) 42.86 (n = 9) .064 38.10 (n = 8) 19.05 (n = 4) 42.86 (n = 9) 21
Physical Health Summary (SF‐36) .920 22.22 (n = 4) 33.33 (n = 6) 44.44 (n = 8) .696 22.22 (n = 4) 38.89 (n = 7) 38.89 (n = 7) .580 22.22 (n = 4) 38.89 (n = 7) 38.89 (n = 7) 18
Mental Health Summary (SF‐36) .262 50.00 (n = 9) .00 (n = 0) 50.00 (n = 9) .057 50.00 (n = 9) 5.56 (n = 1) 44.44 (n = 8) .000 50.00 (n = 9) 5.56 (n = 1) 44.44 (n = 8) 18
Activities of Daily Living (B‐ADL) .603 10.00 (n = 2) 80.00 (n = 16) 10.00 (n = 2) .613 10.00 (n = 2) 70.00 (n = 14) 20.00 (n = 4) .313 40.00 (n = 8) 30.00 (n = 6) 30.00 (n = 6) 20
Subjective Memory Functioning (FAI) .147 14.29 (n = 3) 76.19 (n = 16) 9.52 (n = 2) .114 .00 (n = 0) 90.48 (n = 19) 9.52 (n = 2) .346 .00 (n = 0) 90.48 (n = 19) 9.52 (n = 2) 21

Abbreviations: B‐ADL, Bayer Activities of Daily Living Scale; BDI‐II, Beck Depression Inventory; d ppc2, effect size Cohen d pretest‐posttest design; FAI, Forgetfulness Assessment Inventory; MCI, mild cognitive impairment group; PD‐BMT, best medically treated Parkinson disease group; PD‐DBS, Parkinson disease patients with deep brain stimulation; SF‐36, Short Form (36) Health Survey; ⇓, deterioration in %; ⇔, no changes in %; ⇑, improvement in %.